imatinib krka 100 mg
krka - imatinib - 44 - cytostatica
imatinib fair-med 400 mg
fair-med healthcare gmbh - imatinib - 44 - cytostatica
imatinib fair-med 100 mg
fair-med healthcare gmbh - imatinib - 44 - cytostatica
sevelamer carbonate heaton 800 mg filmom obalené tablety
heaton k.s., Česká republika - sevelamér - 87 - varia i
imatinib amomed 400 mg
amomed pharma gmbh - imatinib - 44 - cytostatica
imatinib amomed 100 mg
amomed pharma gmbh - imatinib - 44 - cytostatica
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastické činidlá - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
erleada
janssen-cilag international nv - apalutamide - prostatické nádory - endokrinná terapia - erleada je uvedené:v dospelých mužov na liečbu non metastatickým kastrácia rezistentný karcinóm prostaty (nmcrpc), ktorí majú vysoké riziko vzniku metastázy. v dospelých mužov na liečbu metastatickým hormón-citlivé rakovinu prostaty (mhspc) v kombinácii s androgén deprivácie terapia (pdo).
ecomectin 6 mg/g premix na medikovanie kŕmnej zmesi pre ošípané
eco animal health europe, Írsko - prm.
fertigest 0,004 mg /ml injekčný roztok
vetpharma animal health, Španielsko - inj.